Through the experiment, it was found out that CD8A and CXCL6 showed higher positive expression in both LIHC tissues and most human liver cancer cell lines, which implied that both PRDEGs might be potential biomarkers for the diagnosis and treatment of LIHC. This evidence concerns the gene CD8A and liver cancer.